The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease
Open accessAbstract
Background Although many predictors of disease severity of nonalcoholic fatty liver disease (NAFLD) have been proposed, studies of the potential effects of specific environmental exposures on human NAFLD are lacking. Smoking increases insulin resistance. Given the pathophysiological role of insulin resistance in NAFLD, characterization of the influence of smoking in NAFLD is warranted. Aim To study the potential association between cigarette smoking and advanced fibrosis in NAFLD. Methods All adults enrolled in the NASH CRN studies between October 2004 and February 2008 who had liver biopsies were included (n=1091). Advanced fibrosis was defined as stages 3-4. Analyses were performed. Results Significant bivariate associations were demonstrated between advanced fibrosis and age, gender, ethnicity, diabetes, and smoking history. History of smoking >=10 pack-years was more common (p<0.0001) among patients with advanced fibrosis. Multivariate analysis demonstrated an association between smoking history of >=10 pack-years and advanced fibrosis (OR=1.63). Among non-diabetics, history of >=10 pack-years was associated with an OR of 2.48 for advanced fibrosis. High frequencies of advanced fibrosis were observed among diabetics (with or without >=10 pack-years history) and non-diabetics with >=10 pack-years history as compared to non-diabetics without significant smoking history. Conclusions Smoking history was associated with advanced liver fibrosis in this large multicenter cohort of NAFLD patients. The results indicate that smoking may enhance the progression of NAFLD partly through its effect on insulin resistance. Our results are consistent with recent animal studies suggesting that cigarette smoke may aggravate fatty liver. To our knowledge, this is the first study to show that cigarette smoking is associated with increased fibrosis severity in human NALFD, suggesting it may accelerate disease progression. These results may support a formal recommendation of smoking cessation in patients with NAFLD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Self-citationModerate Alcohol Consumption Lowers the Risk of Type 2 Diabetes
Koppes, L. L. J., Dekker, J. M., Hendriks, H. F. J., Bouter, L. M., & Heine, R. J. (2005) · Diabetes Care · doi:10.2337/diacare.28.3.719 · Cited by 671
Will, J. C., Galuska, D. A., Ford, E. S., Mokdad, A., & Calle, E. E. (2001) · International Journal of Epidemiology · doi:10.1093/ije/30.3.540 · Cited by 376
Sierksma, A., van der Gaag, M., Kluft, C., & Hendriks, H. (2002) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601459 · Cited by 231 · cited 1×
“Another possible mechanism is the anti-inflammatory action of mild to moderate alcohol consumption [43].”
Background
Cited by
Vos, M. B., Abrams, S. H., Barlow, S. E., Caprio, S., Daniels, S. R., Kohli, R., Mouzaki, M., Sathya, P., Schwimmer, J. B., Sundaram, S. S., et al. (2017) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001482 · Cited by 1,008
Musso, G., Gambino, R., Tabibian, J. H., Ekstedt, M., Kechagias, S., Hamaguchi, M., Hultcrantz, R., Hagström, H., Yoon, S. K., Charatcharoenwitthaya, P., et al. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001680 · Cited by 720
Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome
Lonardo, A., Ballestri, S., Marchesini, G., Angulo, P., & Loria, P. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2014.09.020 · Cited by 685
Musso, G., Cassader, M., Rosina, F., & Gambino, R. (2012) · Diabetologia · doi:10.1007/s00125-011-2446-4 · Cited by 661
Karlsen, T. H., Sheron, N., Zelber-Sagi, S., Carrieri, P., Dusheiko, G., Bugianesi, E., Pryke, R., Hutchinson, S. J., Sangro, B., Martin, N. K., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(21)01701-3 · Cited by 652
Metadata
- Authors
- Zein, C. O., Unalp, A., Colvin, R., Liu, Y.-C., & McCullough, A. J.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2011-04
- Volume
- 54
- Issue
- 4
- Pages
- 753-759
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2036748338
- Cited by
- 227
- References
- 4
- FWCI
- 6.29
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease. https://app.cochat.ai/papers/10.1016/j.jhep.2010.07.040
- The paper
- Zein, C. O., Unalp, A., Colvin, R., Liu, Y.-C., & McCullough, A. J. (2011). Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease. Journal of Hepatology. https://doi.org/10.1016/j.jhep.2010.07.040
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.